1. Unzueta A, Valdez R, Chang YH, Desmarteau YM, Heilman RL, Scott RL, Douglas DD, Rakela J. Hepatitis E virus serum antibodies and RNA prevalence in patients evaluated for heart and kidney transplantation. Ann Hepatol 2016 Jan-Feb; 15 (1):33-40
    View PubMed
  2. Unzueta A, Rakela J. Hepatitis E infection in liver transplant recipients. Liver Transpl. 2014 Jan; 20(1):15-24.
    View PubMed
  3. Unzueta A, Vargas HE. Nonsteroidal anti-inflammatory drug-induced hepatoxicity. Clin Liver Dis 2013 Nov; 17 (4):643-56, ix Epub 2013 Sept 04
    View PubMed
  4. Unzueta A, Gallegos-Orozco JF. Noninvasive diagnosis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. OGH Reports. 2013; 2(2):8-16.
  5. Unzueta A, Yamamoto JK, Uscanga LF. Lack of response to infliximab as treatment for preventing colectomy in patients with severe ulcerative colitis. Am J Gastroenterol. 2002; 97:S165.
  6. Unzueta-Santos A, Yamamoto-Furusho JK, Uscanga-Dominguez LF. Infliximab experience in inflammatory bowel disease (in Spanish). Rev Gastroenterol Mex. 2002; 67:A215.